Acasti Pharma is a biopharmaceutical dedicated to R&D and commercialization of innovative proprietary APIs for the management of cardio metabolic disorders through novel superior approach with prescription drugs and medical foods.
Certified accurate pedometers and activity wellness programs are helping American’s walk to wellness. Stop by and see the new Accelerometer Pedometer. Accurate even worn at a tilt!
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company is based in Cambridge, Massachusetts and has an established international presence.
Amarin Pharma Inc.
Amarin Pharma Inc. is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's first FDA approved product is available in the United States by prescription.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Atherotech's proprietary VAP® Lipid Panel enables clinicians to accurately stratify a patient’s risk and deliver personalized treatment to improve health outcomes.
B. Braun Medical Inc.
The H.E.L.P. (Heparin-induced Extracorporeal Lipoprotein Precipitation) System provided in the U.S. by B. Braun Medical is a proven procedure, known as LDL Apheresis, which selectively removes low density lipoproteins for the treatment of severe cholesterolemia. Stop by the B. Braun booth to see the Plasmat® Futura Treatment System. For additional information, please call 800-848-2066.
Carlson Laboratories began with a single vitamin E formula. Since then, it has grown to become the world’s most complete line of natural-source vitamin E products. Our product range has expanded and includes award-winning Norwegian fish oils, a full line of vitamins, minerals, amino acids, special formulations and other supplements.
Cleveland Heartlab, Inc.
Cleveland HeartLab, Inc. is a premier, next-generation clinical reference laboratory committed to advancing cardiovascular risk assessment through unique and proprietary diagnostic tests. We focus on novel inflammatory and cardiovascular biomarker technologies that allow for personalized treatment recommendations.
diaDexus, Inc., based in South San Francisco California, USA develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The diaDexus PLAC® Test is a simple blood test that measures Lp-PLA2, a vascular-specific inflammatory marker critical in the formation of rupture-prone plaque. Visit www.plactest.com for more information.
DuPont Nutrition & Health addresses the world's challenges in food by offering a wide range of ingredients to provide healthier and more nutritious food.
Endurance Products Company
Endurance Products Company (EPC) , is the exclusive marketing affiliate of Innovite Inc, manufacturer of select nutritional supplements which feature the proprietary wax-matrix, controlled-release technology. Endur-acin® is our best-selling, extended-release nicotinic acid, which has consistently demonstrated good clinical results and unsurpassed patient tolerability in controlled clinical studies.
The Foundation for Health Improvement and Technology (FHIT)
The Foundation for Health Improvement and Technology (FHIT) is dedicated to worldwide, high-level education of physicians and other clinical and laboratory professionals on the widespread utility of biomarkers in cardiometabolic disease prevention and treatment through early and accurate risk assessment, therapeutic guidance and goals.
Genzyme - A Sanofi Company
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with approximately 10,000 employees in locations spanning the globe and 2009 revenues of $4.5 billion.
Health Diagnostic Laboratory, Inc.
Health Diagnostic Laboratory, Inc. (HDL, Inc.) is a leader in health management offering a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes, and related diseases. HDL, Inc.’s systematic approach identifies factors contributing to disease and can provide a basis for personalized treatment, allowing physicians to more effectively manage patients. Individuals receive a personalized overview of their risk factors along with intensive counseling from expert Clinical Health Consultants at no additional cost, improving compliance and enhancing satisfaction. HDL, Inc. is a CLIA-certified, CAP-accredited laboratory.
The mission of the Lipoprotein(a) Foundation is to prevent cardiovascular events due to high Lipoprotein(a) by revealing this inherited risk for cardiovascular disease, empowering patients and saving lives. Our goal is to save lives by increasing awareness, advocating for routine testing, and a specific treatment for high Lipoprotein(a). It is estimated that 1 in 5 Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease.
Kaneka Pharma America LLC
There is hope for your patients with hypercholesterolemia!
LIPOSORBER® LDL Apheresis
Beyond Diet and Drug Therapy
For Acute Lowering of LDL-C 73%-83%
Kowa Company, Ltd.
Kowa Company, Ltd. (Kowa) is a privately held multinational company headquartered in Nagoya, Japan. Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceuticals, life science, information technology, textiles, machinery and various consumer products. Kowa's pharmaceutical division is focused on cardiovascular therapeutics, and the company’s flagship product, LIVALO® (pitavastatin) was launched in the United States in June 2010. For more information about Kowa Pharmaceuticals America, visit www.kowapharma.com.
LipoScience Inc, offers the NMR LipoProfile® test, the only FDA-cleared blood test that directly quantifies LDL particles. LDL-P by NMR is a more clinically reliable measure of LDL used to manage patients with increased CVD risk.
Today's Merck is a global healthcare leader working to help the world be well.
ReachMD is an award-winning producer and distributor of healthcare information and education for medical professionals nationwide. Leveraging first-to-market, proprietary broadcast technologies to deliver compelling digital content across multiple platforms. ReachMD programs broadcast 24/7 on iHeart Radio and TuneIn Radio channels, streamed simulcast on ReachMD.com, and offered on-demand through free mobile apps.
Sanofi and Regeneron
Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients' needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi and Regeneron have collaborated to develop and commercialize fully human monoclonal antibodies utilizing proprietary technologies.
Co-founded by a practicing cardiologist, Step One Foods produces convenient foods for heart health that contain scientifically-proven levels of phytosterols, Omega 3s, antioxidants, and fiber.
Synageva BioPharma Corporation is a biopharmaceutical company working to deliver breakthrough medicines globally for patients suffering from rare, devastating diseases. Our lead program, sebelipase alfa (SBC-102), is a recombinant human enzyme replacement therapy for Lysosomal Acid Lipase Deficiency (LAL D), a lysosomal storage disorder (LSD).